Protecting Patients With Blood Cancers From COVID-19
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
May is National Cancer Research Month. On Thursday, the American Association for Cancer Research (AACR) received a letter from...
The cancer research community has made dramatic progress in the past few decades. AACR President David A. Tuveson, MD, PhD, FAACR, cited metastatic melanoma, the...
By Nicholas Warren, PhD On Thursday, the U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) announced...
With President Joseph R. Biden in the White House, the United States may be poised to make a major...
The Opening Ceremony of AACR Annual Meeting 2021 set the stage for a dynamic forum for presenting and sharing...
Women have played many pivotal roles at the American Association for Cancer Research (AACR), from the organization’s earliest years...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
By Nicholas Warren, PhD Lung cancer is the deadliest cancer in the United States, killing more than 135,000 Americans...
Last month, the United States officially rejoined the Paris Agreement, an international treaty adopted in 2015 that aims to reduce carbon emissions and mitigate the effects of climate...